GLP-1 Management App That Personalizes Dosing Based on Patient Data ($1M-$10M ARR)

DoseRight tackles the frustrating challenge of GLP-1 medication dosing that plagues Ozempic and Wegovy patients. The app builds tailored titration protocols by analyzing your wearable device inputs, medication background, and live symptom reporting. It tracks blood glucose levels, weight fluctuations, and adverse reactions, then fine-tunes your regimen to deliver peak effectiveness with the fewest possible side effects. What patients get from DoseRight: • Customized dosing timelines shaped by your individual body's response • Side effect monitoring with escalation alerts based on severity • Seamless connections to CGMs, smart scales, and fitness trackers • Timely medication reminders plus refill logistics support For healthcare practices ($499/month), the platform delivers: • Comprehensive patient monitoring dashboards • Seamless EHR connectivity out of the box • Proactive alert systems flagging worrisome symptom patterns Priced at $19/month for individual users, the addressable market is enormous — 37+ million Americans with diabetes and a rapidly expanding population turning to GLP-1s for weight management. The go-to-market strategy centers on engaging digital health influencers and tapping into online communities hungry for superior management solutions. Ultimately, DoseRight evolves into the central platform for any medication that demands variable dosing — amplifying therapeutic benefits while minimizing unwanted reactions, transforming what was once trial-and-error into data-driven precision care.

What you get with the full dossier